JWTXF yields 4.14% · PFE yields 6.13%● Live data
📍 JWTXF pulled ahead of the other in Year 1
Combined, JWTXF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JWTXF + PFE for your $10,000?
The Japan Wool Textile Co., Ltd. operates in the textile industry in Japan. It operates through four business lines: Textile & Clothing Materials, Industrial Machinery & Materials, Human & Future Development, and Consumer Goods & Services. The Textile & Clothing Materials business manufactures and sells knitting wool for fabric/knitting, uniform-related materials and products, and men's and women's fashion materials. The Industrial Machinery & Materials business is involved in the development, manufacture, and sale of various materials, including wool, chemical synthetic fibers, and threads through twine/felt/non-woven fabrics. It also designs, manufactures, and sells industrial machinery; and designs, installs, and maintains environmental/energy systems. The Human & Future Development business provides daycare, childcare/after-school care, small group home care, welfare equipment rental and sales, and house renovations services, as well as engages in the commercial facility operation, Children's amusement facility, ice cream, video rental, snack sales, and cellular phone businesses. It also operates tennis schools, golf courses, driving ranges, and equestrian clubs, as well as Karaoke and bowling alleys; rental of office buildings; provision of rental office management services; and sale of residential land and construction of houses. The Consumer Goods & Services business provides ballroom dance attires, office and industrial use inks, clothing, horse gear and other equestrian products, and stamps and stamp-related products and services; and insurance agency and logistics services, as well as offers beds and bedding, furniture, and other related goods online. The company was incorporated in 1896 and is headquartered in Osaka, Japan.
Full JWTXF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.